Group One Trading’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.4M Sell
1,546,500
-2,009,800
-57% -$53.5M 0.08% 227
2025
Q4
$88.6M Buy
3,556,300
+406,800
+13% +$10.3M 0.15% 116
2025
Q3
$80.2M Buy
3,149,500
+500
+0% +$12.3K 0.14% 131
2025
Q2
$76.3M Sell
3,149,000
-468,200
-13% -$10.9M 0.17% 89
2025
Q1
$91.7M Buy
3,617,200
+61,900
+2% +$1.62M 0.27% 53
2024
Q4
$94.3M Buy
3,555,300
+2,023,700
+132% +$54.9M 0.22% 62
2024
Q3
$44.3M Buy
1,531,600
+419,300
+38% +$12.2M 0.13% 111
2024
Q2
$31.1M Buy
1,112,300
+502,700
+82% +$13.8M 0.12% 124
2024
Q1
$16.9M Sell
609,600
-97,300
-14% -$2.7M 0.07% 236
2023
Q4
$20.4M Buy
706,900
+379,400
+116% +$11.5M 0.05% 340
2023
Q3
$10.9M Sell
327,500
-7,300
-2% -$258K 0.04% 485
2023
Q2
$12.3M Sell
334,800
-394,700
-54% -$15.4M 0.04% 420
2023
Q1
$29.8M Sell
729,500
-2,352,500
-76% -$102M 0.11% 130
2022
Q4
$158M Sell
3,082,000
-510,400
-14% -$24.5M 0.37% 30
2022
Q3
$157M Sell
3,592,400
-258,700
-7% -$12.6M 0.31% 28
2022
Q2
$202M Sell
3,851,100
-2,298,400
-37% -$117M 0.32% 30
2022
Q1
$318M Sell
6,149,500
-1,360,300
-18% -$70.6M 0.32% 28
2021
Q4
$443M Sell
7,509,800
-662,700
-8% -$32.8M 0.36% 27
2021
Q3
$351M Buy
8,172,500
+5,366,200
+191% +$238M 0.38% 28
2021
Q2
$110M Sell
2,806,300
-1,273,400
-31% -$49.5M 0.13% 102
2021
Q1
$148M Buy
4,079,700
+10,600
+0.3% +$376K 0.22% 48
2020
Q4
$150M Buy
4,069,100
+2,326,627
+134% +$85.3M 0.26% 37
2020
Q3
$60.7M Sell
1,742,473
-99,919
-5% -$3.5M 0.19% 75
2020
Q2
$57.2M Buy
1,842,392
+848,365
+85% +$28.8M 0.26% 53
2020
Q1
$30.8M Buy
994,027
+409,373
+70% +$13.9M 0.25% 63
2019
Q4
$21.7M Sell
584,654
-204,265
-26% -$7.28M 0.15% 129
2019
Q3
$26.9M Sell
788,919
-125,110
-14% -$4.55M 0.22% 67
2019
Q2
$37.6M Buy
914,029
+356,147
+64% +$14.1M 0.34% 31
2019
Q1
$22.5M Sell
557,882
-456,593
-45% -$18.3M 0.25% 55
2018
Q4
$42M Sell
1,014,475
-544,075
-35% -$22.6M 0.36% 38
2018
Q3
$65.2M Sell
1,558,550
-325,897
-17% -$12.5M 0.51% 17
2018
Q2
$64.9M Buy
1,884,447
+305,450
+19% +$10.4M 0.55% 11
2018
Q1
$53.2M Buy
1,578,997
+396,514
+34% +$13.6M 0.54% 12
2017
Q4
$40.6M Buy
1,182,483
+358,360
+43% +$12.2M 0.29% 53
2017
Q3
$27.9M Buy
824,123
+483,470
+142% +$15.5M 0.25% 65
2017
Q2
$10.9M Sell
340,653
-57,021
-14% -$1.8M 0.11% 196
2017
Q1
$12.9M Sell
397,674
-17,391
-4% -$548K 0.15% 136
2016
Q4
$12.8M Sell
415,065
-232,513
-36% -$7.1M 0.12% 170
2016
Q3
$20.8M Sell
647,578
-175,596
-21% -$5.87M 0.23% 76
2016
Q2
$27.5M Buy
823,174
+34,255
+4% +$1.09M 0.33% 48
2016
Q1
$22.2M Buy
788,919
+401,890
+104% +$11.5M 0.31% 42
2015
Q4
$11.9M Sell
387,029
-208,270
-35% -$6.55M 0.14% 130
2015
Q3
$17.7M Buy
595,299
+481,678
+424% +$15.4M 0.25% 55
2015
Q2
$3.62M Buy
113,621
+112,778
+13,378% +$3.68M 0.05% 448
2015
Q1
$28K Buy
+843
New +$26.8K ﹤0.01% 3715

Other funds holding PFE

Group One Trading's PFE Position: Q1 2026 in Review

Group One Trading increased its Pfizer (PFE) stake by 271% in Q1 2026, buying an estimated $11.5M and bringing the position to 592,233 shares worth $16.6M. The position accounts for 0.03% of the portfolio, ranked #579.

Group One Trading first reported a position in PFE in Q4 2014 and has held it in 32 quarters since. The position peaked at $32.9M in Q2 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Group One Trading held 592,233 shares of Pfizer worth $16.6M as of Q1 2026.
  • Group One Trading bought 432,806 Pfizer shares in Q1 2026, an estimated $11.5M.
  • Pfizer made up 0.03% of Group One Trading's portfolio in Q1 2026, its #579 holding.
  • Group One Trading first reported a position in Pfizer in Q4 2014 and has held it in 32 quarters since.
  • Group One Trading's Pfizer position peaked at $32.9M in Q2 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.